Assessment of tumour cell proliferation (Ki67) and MVD (CD31) via IHC in tumours from 4 different models treated with BGJ398 for 7 days showed that BGJ398 treatment resulted in not only a significant reduction in cancer cell proliferation but also a significant reduction in MVD. This evidence concerns the gene MKI67 and neoplasm.